Sphingolipid Metabolites Profiling in Hair Growth
January 2018
in “
한국피부장벽학회지
”
New to ceramide? There is a guide in the encyclopedia. Read the guide → Studysummary This study suggests that decreased levels of dihydroceramide in hair may serve as a biomarker for the progression of alopecia.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This study developed a quantitation method for sphingolipids in animal and human hair using liquid chromatography linked tandem mass spectrometry (LC-MS/MS). It measured lipid contents such as sphingoid bases, sphingoid bases 1-phosphate, Ceramide (Cer), and dihydroceramide (DHCer). The method was evaluated for specificity, carryover, linearity, calibration, correlation of determination (R2), LOD, LOQ, precision, accuracy, and recovery. Results showed higher DHCer levels in normal hair roots compared to distal tips, with levels ranging from 1960.23 to 1373.24 pmol/g. In alopecia patients, DHCer levels were significantly lower in upper hair fibers compared to side hair fibers, and specific ceramides (C16:0 and C24:1) were very low in upper hair. In an experimental mouse model of alopecia, both Cer and DHCer were significantly low. These findings suggested that DHCer content in hair could be a potential biomarker for alopecia progression.
